Since prostate cancer is usually slow-growing, Prolaris looks at the genes a patient has after being diagnosed with prostate cancer. In understanding the genes in a specific patient, you’re able to see how aggressive the cancer is and how fast it is growing. The Prolaris test not only allows a doctor and their patient to know the aggressiveness of the cancer, it also helps determine what treatment option is best for that specific patient, and how the patient is likely to respond to the recommended treatment.
Cancer is a broad spectrum and not all prostate cancer is the same. Therefore, each patient diagnosed with prostate cancer should be treated on a case by case basis. Unfortunately, many men diagnosed with prostate cancer often decide to choose more aggressive treatment because they are scared, even when they don’t need aggressive treatment. Prolaris can help with anxiety and worry by giving a patient a ten-year prostate cancer mortality. Knowing this information can help establish if a patient does, in fact, need more aggressive treatment or if he can choose a more mild treatment plan. Most importantly, Prolaris can help determine if a patient is a good candidate for active surveillance or if they should consider more aggressive treatment.